PBI-6DNJ, an orally active and potent multivalent glycosidase inhibitor, demonstrates significant inhibition activity against alpha-glucosidase from mice, featuring a K i value of 0.14 µM. It also exhibits notable hypoglycemic activity, making it suitable for type 2 diabetes research [1].
Molekulargewicht:
2528.6
Formel:
C120H146N26O36
Target-Kategorie:
Glucosidase|||Others|||glycosidase
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
